Stephens Consulting’s Biohaven BHVN Stock Holding History

Stephens Consulting’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30	Closed	-$722	–	1301
2025 Q1	$722	Buy	+30	New	+$1.06K	﹤0.01%	804

Other funds holding BHVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Stephens Consulting's BHVN Position: Q2 2025 in Review

Stephens Consulting sold out of Biohaven (BHVN) in Q2 2025, closing a stake of 30 shares — an estimated $722 sold.

Stephens Consulting first reported a position in BHVN in Q1 2025 and held it in 1 quarter. The position peaked at $722 in Q1 2025. 249 funds tracked by Wall St. Rank hold BHVN as of Q2 2025.

Stephens Consulting reported no remaining Biohaven position as of Q2 2025 after selling out during the quarter.
Stephens Consulting sold 30 Biohaven shares in Q2 2025, an estimated $722.
Stephens Consulting first reported a position in Biohaven in Q1 2025 and held it in 1 quarter.
Stephens Consulting's Biohaven position peaked at $722 in Q1 2025.
249 funds tracked by Wall St. Rank held Biohaven as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.